In Vitro Activity of Coumermycin A1
AUTOR(ES)
Fedorko, Joseph
RESUMO
The in vitro activity of coumermycin A1 was compared with that of novobiocin, ampicillin, and minocycline. Coumermycin was found to be the most active antibiotic of the four against Staphylococcus aureus. It was about 50 times more active than novobiocin or minocycline against the strains tested. Coumermycin also showed good activity against group A streptococci and pneumococci, moderate activity against Escherichia coli, indole-positive Proteus species, and Pseudomonas aeruginosa, and poor activity against Klebsiella-Enterobacter and enterococci. Against P. mirabilis, however, coumermycin activity was almost equal to that of ampicillin. The new antibiotic was further found to be greatly reduced in activity in the presence of plasma, but its minimal inhibitory concentration was not greatly affected by inoculum size. Coumermycin was found to be bacteriostatic in its action, and resistance to it developed slowly. Also, cross-resistance was present with novobiocin but absent with ampicillin or minocycline.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=378103Documentos Relacionados
- In Vitro Activity of Coumermycin A1 Against Mycobacterium tuberculosis var. hominis
- Effect of Mg2+ and Ethylenediaminetetraacetate on the In Vitro Activity of Coumermycin A1 and Novobiocin Against Gram-Negative Bacteria
- Mutations in Bartonella bacilliformis gyrB Confer Resistance to Coumermycin A1
- Herpes simplex virus cloned DNA fragments induce coumermycin A1 resistance in Escherichia coli.
- Identification of the Coumermycin A1 Biosynthetic Gene Cluster of Streptomyces rishiriensis DSM 40489
